Ankylosing spondylitis (AS) is a chronic inflammatory disorder that predominantly affects the axial skeleton, leading to progressive spinal fusion and reduced flexibility. The resultant rigidity of ... For decades, ankylosing spondylitis was considered a man’s disease, but new research reveals something shocking: ankylosing spondylitis hits women differently and nearly as frequently as men, yet ...
Ankylosing spondylitis (AS), a type of arthritis that affects joints, tendons, and ligaments in the lower back and the base of the spine, can make you feel as if your energy has been zapped. It’s a ... Healio: ‘Surprising and good’: Bimekizumab shows strong 5-year efficacy in ankylosing spondylitis The American Journal of Managed Care: Bimekizumab Shows Long-Term Efficacy in Nonradiographic AxSpA, Ankylosing Spondylitis Bimekizumab demonstrated safety and efficacy at 2 years among patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS). Bimekizumab is currently FDA approved ...
ankylosing spondylitis and bone spurs, Healio: Median survival of first-line TNF inhibitor in ankylosing spondylitis nearly 11 years Median survival of first-line TNF inhibitor in ankylosing spondylitis nearly 11 years Tumor necrosis factor inhibitors may offer mental health benefits in the management of patients with ankylosing spondylitis.
